No abstract

In analogy to the ESS, the BFS shows to be a unique and precise instrument assessing symptomatic fatigue with respect to rest propensity.

Sleep-related bruxism may directly impact sleep quality. This study aims to evaluate potential relationships between sleep bruxism events and related daytime symptoms. We investigated 22 patients (42.1 ± 11.6 yr of age) with sleep bruxism in comparison with 12 good sleeper control subjects of similar age (41.0 ± 11.5 yr). Sleep bruxism was visually analyzed and categorized according to sleep stage, bruxism type (tonic/phasic) and duration. Clinical instruments comprised the Epworth Sleepiness, the Brugmann Fatigue Scale, and the Hospital Anxiety and Depression Rating Scale. Sleep quality was measured using the Pittsburgh Sleep Quality Index. Controls and patients with sleep bruxism presented similar sleep architecture. However, patients with sleep bruxism displayed significantly decreased sleep efficiency and higher sleep fragmentation. Perceived sleep quality was significantly worse in patients with sleep bruxism than in control subjects. Additionally, patients presented with significantly greater fatigue intensity and more affective symptoms than controls. The cumulative durations of sleep bruxism events (phasic, tonic, and combined) were significantly correlated with deterioration of sleep quality, whereas neither the event index per hour of sleep nor the count of event types (phasic/tonic) were related to sleep quality. Patients with sleep bruxism present with higher levels of daytime fatigue and sleepiness than control subjects who experience good sleep and may also exhibit impairments of sleep quality which are related to the duration of bruxism occurrence rather than to its frequency.

Background: Restless leg syndrome (RLS) and periodic limb movement (PLM) disorder (PLMD) can affect sleep quality and interfere with daytime functioning. Whether the co-morbidity of RLS further worsens daytime symptoms, sleep architecture and quality in patients with PLMs, is not yet fully clarified. Methods: Sleep (polysomnography) and daytime symptoms of 47 drug-free patients, assigned to isolated PLMD or co-morbid RLS subgroups, were compared to controls in a retrospective cohort-study (n = 501). Associations between perceived sleep quality, fatigue, sleepiness, mood and sleep variables were explored descriptively. Results: Although co-morbid patients showed worsened sleep quality, both patient groups showed similar sleepiness and affective symptoms. While significantly differing from controls, patients presented similarly increased light sleep, decreased slow-wave sleep and lowered sleep efficiency. Altered sleep quality, fatigue and sleepiness were significantly correlated to decreased slow-wave sleep and sleep fragmentation. Affective symptoms, fatigue and perceived sleep quality also correlated to PLM index. Conclusions: Sleep structure and efficiency were similarly impacted in isolated PLMD and in co-morbid RLS. RLS mainly worsened perceived sleep quality. Given that systematic treatment for isolated PLMD is currently not recommended, such results may question whether no or different-from-RLS treatment strategies are compatible with optimal care.